Price rollbacks, Medicare negotiations, fines and more: Pharma's likely to hate House pricing plan

Pharma took notice when a draft version of House Democrats' pricing plan leaked last week. Now, It's official: The industry faces an aggressive proposal to allow price negotiation on top brands, price-hike rollbacks, fines for offenders and more. But does the bill stand a chance?